Global In-vitro Diagnostic Services Market Size, Status and Forecast 2021-2027
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
- 1.2.2 Infectious Testing
- 1.2.3 Diabetes Testing
- 1.2.4 Molecular Testing
- 1.2.5 Tissue Testing
- 1.3 Market by Application
- 1.3.1 Global In-vitro Diagnostic Services Market Share by Application: 2016 VS 2021 VS 2027
- 1.3.2 Hospitals
- 1.3.3 Point-Of-Care Testing
- 1.3.4 Laboratories
- 1.3.5 Academic Institutes
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global In-vitro Diagnostic Services Market Perspective (2016-2027)
- 2.2 In-vitro Diagnostic Services Growth Trends by Regions
- 2.2.1 In-vitro Diagnostic Services Market Size by Regions: 2016 VS 2021 VS 2027
- 2.2.2 In-vitro Diagnostic Services Historic Market Share by Regions (2016-2021)
- 2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Regions (2022-2027)
- 2.3 In-vitro Diagnostic Services Industry Dynamic
- 2.3.1 In-vitro Diagnostic Services Market Trends
- 2.3.2 In-vitro Diagnostic Services Market Drivers
- 2.3.3 In-vitro Diagnostic Services Market Challenges
- 2.3.4 In-vitro Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top In-vitro Diagnostic Services Players by Revenue
- 3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2016-2021)
- 3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2016-2021)
- 3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
- 3.4 Global In-vitro Diagnostic Services Market Concentration Ratio
- 3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2020
- 3.5 In-vitro Diagnostic Services Key Players Head office and Area Served
- 3.6 Key Players In-vitro Diagnostic Services Product Solution and Service
- 3.7 Date of Enter into In-vitro Diagnostic Services Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Diagnostic Services Breakdown Data by Type
- 4.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2016-2021)
- 4.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2022-2027)
5 In-vitro Diagnostic Services Breakdown Data by Application
- 5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2016-2021)
- 5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2022-2027)
6 North America
- 6.1 North America In-vitro Diagnostic Services Market Size (2016-2027)
- 6.2 North America In-vitro Diagnostic Services Market Size by Type
- 6.2.1 North America In-vitro Diagnostic Services Market Size by Type (2016-2021)
- 6.2.2 North America In-vitro Diagnostic Services Market Size by Type (2022-2027)
- 6.2.3 North America In-vitro Diagnostic Services Market Size by Type (2016-2027)
- 6.3 North America In-vitro Diagnostic Services Market Size by Application
- 6.3.1 North America In-vitro Diagnostic Services Market Size by Application (2016-2021)
- 6.3.2 North America In-vitro Diagnostic Services Market Size by Application (2022-2027)
- 6.3.3 North America In-vitro Diagnostic Services Market Size by Application (2016-2027)
- 6.4 North America In-vitro Diagnostic Services Market Size by Country
- 6.4.1 North America In-vitro Diagnostic Services Market Size by Country (2016-2021)
- 6.4.2 North America In-vitro Diagnostic Services Market Size by Country (2022-2027)
- 6.4.3 United States
- 6.4.3 Canada
7 Europe
- 7.1 Europe In-vitro Diagnostic Services Market Size (2016-2027)
- 7.2 Europe In-vitro Diagnostic Services Market Size by Type
- 7.2.1 Europe In-vitro Diagnostic Services Market Size by Type (2016-2021)
- 7.2.2 Europe In-vitro Diagnostic Services Market Size by Type (2022-2027)
- 7.2.3 Europe In-vitro Diagnostic Services Market Size by Type (2016-2027)
- 7.3 Europe In-vitro Diagnostic Services Market Size by Application
- 7.3.1 Europe In-vitro Diagnostic Services Market Size by Application (2016-2021)
- 7.3.2 Europe In-vitro Diagnostic Services Market Size by Application (2022-2027)
- 7.3.3 Europe In-vitro Diagnostic Services Market Size by Application (2016-2027)
- 7.4 Europe In-vitro Diagnostic Services Market Size by Country
- 7.4.1 Europe In-vitro Diagnostic Services Market Size by Country (2016-2021)
- 7.4.2 Europe In-vitro Diagnostic Services Market Size by Country (2022-2027)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific In-vitro Diagnostic Services Market Size (2016-2027)
- 8.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Type
- 8.2.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2016-2021)
- 8.2.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2022-2027)
- 8.2.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2016-2027)
- 8.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Application
- 8.3.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2016-2021)
- 8.3.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2022-2027)
- 8.3.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2016-2027)
- 8.4 Asia-Pacific In-vitro Diagnostic Services Market Size by Region
- 8.4.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2016-2021)
- 8.4.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2022-2027)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America In-vitro Diagnostic Services Market Size (2016-2027)
- 9.2 Latin America In-vitro Diagnostic Services Market Size by Type
- 9.2.1 Latin America In-vitro Diagnostic Services Market Size by Type (2016-2021)
- 9.2.2 Latin America In-vitro Diagnostic Services Market Size by Type (2022-2027)
- 9.2.3 Latin America In-vitro Diagnostic Services Market Size by Type (2016-2027)
- 9.3 Latin America In-vitro Diagnostic Services Market Size by Application
- 9.3.1 Latin America In-vitro Diagnostic Services Market Size by Application (2016-2021)
- 9.3.2 Latin America In-vitro Diagnostic Services Market Size by Application (2022-2027)
- 9.3.3 Latin America In-vitro Diagnostic Services Market Size by Application (2016-2027)
- 9.4 Latin America In-vitro Diagnostic Services Market Size by Country
- 9.4.1 Latin America In-vitro Diagnostic Services Market Size by Country (2016-2021)
- 9.4.2 Latin America In-vitro Diagnostic Services Market Size by Country (2022-2027)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa In-vitro Diagnostic Services Market Size (2016-2027)
- 10.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Type
- 10.2.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2016-2021)
- 10.2.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2022-2027)
- 10.2.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2016-2027)
- 10.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Application
- 10.3.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2016-2021)
- 10.3.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2022-2027)
- 10.3.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2016-2027)
- 10.4 Middle East & Africa In-vitro Diagnostic Services Market Size by Country
- 10.4.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2016-2021)
- 10.4.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2022-2027)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 BioRad
- 11.1.1 BioRad Company Details
- 11.1.2 BioRad Business Overview
- 11.1.3 BioRad In-vitro Diagnostic Services Introduction
- 11.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.1.5 BioRad Recent Development
- 11.2 DexCom
- 11.2.1 DexCom Company Details
- 11.2.2 DexCom Business Overview
- 11.2.3 DexCom In-vitro Diagnostic Services Introduction
- 11.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.2.5 DexCom Recent Development
- 11.3 Nova Biomedical
- 11.3.1 Nova Biomedical Company Details
- 11.3.2 Nova Biomedical Business Overview
- 11.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
- 11.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.3.5 Nova Biomedical Recent Development
- 11.4 OraSure
- 11.4.1 OraSure Company Details
- 11.4.2 OraSure Business Overview
- 11.4.3 OraSure In-vitro Diagnostic Services Introduction
- 11.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.4.5 OraSure Recent Development
- 11.5 Pearl Pathways
- 11.5.1 Pearl Pathways Company Details
- 11.5.2 Pearl Pathways Business Overview
- 11.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
- 11.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.5.5 Pearl Pathways Recent Development
- 11.6 Phenomenex
- 11.6.1 Phenomenex Company Details
- 11.6.2 Phenomenex Business Overview
- 11.6.3 Phenomenex In-vitro Diagnostic Services Introduction
- 11.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.6.5 Phenomenex Recent Development
- 11.7 Qiagen
- 11.7.1 Qiagen Company Details
- 11.7.2 Qiagen Business Overview
- 11.7.3 Qiagen In-vitro Diagnostic Services Introduction
- 11.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.7.5 Qiagen Recent Development
- 11.8 Roche Diagnostics
- 11.8.1 Roche Diagnostics Company Details
- 11.8.2 Roche Diagnostics Business Overview
- 11.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
- 11.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.8.5 Roche Diagnostics Recent Development
- 11.9 Siemens
- 11.9.1 Siemens Company Details
- 11.9.2 Siemens Business Overview
- 11.9.3 Siemens In-vitro Diagnostic Services Introduction
- 11.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.9.5 Siemens Recent Development
- 11.10 Sysmex
- 11.10.1 Sysmex Company Details
- 11.10.2 Sysmex Business Overview
- 11.10.3 Sysmex In-vitro Diagnostic Services Introduction
- 11.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.10.5 Sysmex Recent Development
- 11.11 Thermofisher
- 11.11.1 Thermofisher Company Details
- 11.11.2 Thermofisher Business Overview
- 11.11.3 Thermofisher In-vitro Diagnostic Services Introduction
- 11.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2016-2021)
- 11.11.5 Thermofisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
In-vitro Diagnostic Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Diagnostic Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Segment by Application
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
OraSure